And the data does not capture why each individual was prescribed a GLP-1 medication, which matters because insurance coverage differs significantly depending on whether the medication is prescribed for diabetes, weight management or another indication
Among people using the drugs without diabetes, discontinuation rose to around 65%
For the LC-MS measurement, an Agilent 6220 TOF-MS with a Dual ESI-source and a 1200 HPLC system (Agilent Technologies, Inc., Santa Clara, CA, United States) with a Hypersil Gold C18 column (1.9 m, 50 2.1 mm
[DOI] [PubMed] [Google Scholar] 221.Wang L., Lu D., Wang X., Wang Z., Li W., Chen G
Most studies have a low risk of bias in selective outcome data ( Figures 2 , 3 )